Rocket Science Health validates targeted olfactory-cleft deposition in non-human primates ahead of the 4th Nasal Formulation & Delivery Summit

https://www.news-medical.net/news/20260515/Rocket-Science-Health-validates-targeted-olfactory-cleft-deposition-in-non-human-primates-ahead-of-the-4th-Nasal-Formulation-Delivery-Summit.aspx As the pace of modern drug discovery accelerates, the industry is increasingly recognizing that a breakthrough molecule is only as effective as its ability to reach the target site. Nowhere is this challenge more acute than in treating Central Nervous System (CNS) and brain-related illnesses, where the blood-brain barrier remains a formidable obstacle to traditional delivery. Today, the "how" of drug delivery is becoming as strategically critical as the "what," driving a shift toward innovative routes of administration - such as the intranasal delivery of vaccines and therapeutics - to bypass systemic barriers and improve patient outcomes.